Skip to main content
. 2020 Jul 2;72(4):278–282. doi: 10.1016/j.ihj.2020.06.012

Table 3.

Outcome.

Covered (20) Uncovered (25)
Median follow-up,months 57 (12–129) 35 (14–86)
Upper limb/lower limb BP gradient > 10 mm Hg 3 1
Mean number of anti-hypertensives 1.38 ± 0.74 1 + 0.7
Imaging on follow-up 18 8
Late lumen loss
 No or mild 2 (Advanta 1, CP 1) 4 (CP 3, Palmaz 1)
 Moderate 12 (Advanta 7, CP 4, Andra 1) 4 (CP3, Palmaz 1)
 Severe 4 (Advanta 3, CP 1) 0
 Strut fracture 1 (Advanta) 0